|
| U.S. Brand
Names |
|
| Riopan®[OTC] |

|
|
| Generic
Available |
|
|
Yes |

|
|
| Synonyms |
|
|
Hydromagnesium Aluminate |

|
|
| Pharmacological Index |
|
|
Antacid |

|
|
| Use |
|
|
Symptomatic relief of hyperacidity associated with peptic ulcer, gastritis,
peptic esophagitis and hiatal hernia |

|
|
| Pregnancy Risk
Factor |
|
|
C |

|
|
| Contraindications |
|
|
Patients with colostomy or an ileostomy; appendicitis; ulcerative colitis;
diverticulitis |

|
|
| Adverse
Reactions |
|
|
>10%: Gastrointestinal: Constipation, chalky taste, stomach cramps, fecal
impaction
1% to 10%: Gastrointestinal: Nausea, vomiting, discoloration of feces (white
speckles) |

|
|
| Drug
Interactions |
|
|
Tetracyclines, digoxin, indomethacin, iron salts,
isoniazid |

|
|
| Usual Dosage |
|
|
Adults: Oral: 540-1080 mg between meals and at bedtime |

|
|
| Dietary
Considerations |
|
|
Should be administered on empty stomach |

|
|
| Mental Health: Effects
on Mental Status |
|
|
None reported |

|
|
| Mental Health:
Effects on Psychiatric
Treatment |
|
|
None reported |

|
|
| Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
|
No information available to require special precautions |

|
|
| Dental Health:
Effects on Dental Treatment |
|
|
No effects or complications reported |

|
|
| Patient
Information |
|
|
Chew tablets thoroughly before swallowing with water; notify physician if
relief is not obtained or if signs of bleeding from GI tract
occur |

|
|
| Nursing
Implications |
|
|
Administer 1-2 hours apart from oral drugs; shake suspensions well
Monitor for constipation, fecal impaction, diarrhea, and hypophosphatemia
|

|
|
| Dosage Forms |
|
|
Suspension, oral: 540 mg/5 mL (360 mL) |

|
|
Copyright © 2007 Drugs Area
|